Paige AI technology aims to improve cancer diagnostics and patient outcomes: Cofounded by Thomas Fuchs, Paige is the first company with an FDA-approved AI tool for cancer diagnosis, potentially revolutionizing the healthcare industry through enhanced precision and care.
Fuchs discusses AI’s role in accelerating cancer detection:
- AI models leverage visual pattern recognition to speed up cancer detection in imaging and pathology.
- Paige has demonstrated promising results in using AI for these applications.
- Fuchs highlights the challenges that still exist in cancer detection.
Drawing from diverse experience to advance medical AI:
- Fuchs’ background includes engineering roles at NASA’s Jet Propulsion Laboratory.
- He now serves as Paige’s Chief Scientific Officer and as dean of artificial intelligence and human health at the Icahn School of Medicine at Mount Sinai.
- Fuchs shares his perspective on the future potential of AI in medicine.
Broader implications for AI in healthcare: As a pioneering example, Paige illustrates the transformative impact AI could have on patient care by enabling earlier, more accurate cancer diagnoses. However, challenges remain in fully realizing this potential and thoughtfully integrating AI into medical practice. Fuchs’ multidisciplinary expertise positions him to help drive responsible innovation at the intersection of AI and healthcare.
Recent Stories
DOE fusion roadmap targets 2030s commercial deployment as AI drives $9B investment
The Department of Energy has released a new roadmap targeting commercial-scale fusion power deployment by the mid-2030s, though the plan lacks specific funding commitments and relies on scientific breakthroughs that have eluded researchers for decades. The strategy emphasizes public-private partnerships and positions AI as both a research tool and motivation for developing fusion energy to meet data centers' growing electricity demands. The big picture: The DOE's roadmap aims to "deliver the public infrastructure that supports the fusion private sector scale up in the 2030s," but acknowledges it cannot commit to specific funding levels and remains subject to Congressional appropriations. Why...
Oct 17, 2025Tying it all together: Credo’s purple cables power the $4B AI data center boom
Credo, a Silicon Valley semiconductor company specializing in data center cables and chips, has seen its stock price more than double this year to $143.61, following a 245% surge in 2024. The company's signature purple cables, which cost between $300-$500 each, have become essential infrastructure for AI data centers, positioning Credo to capitalize on the trillion-dollar AI infrastructure expansion as hyperscalers like Amazon, Microsoft, and Elon Musk's xAI rapidly build out massive computing facilities. What you should know: Credo's active electrical cables (AECs) are becoming indispensable for connecting the massive GPU clusters required for AI training and inference. The company...
Oct 17, 2025Vatican launches Latin American AI network for human development
The Vatican hosted a two-day conference bringing together 50 global experts to explore how artificial intelligence can advance peace, social justice, and human development. The event launched the Latin American AI Network for Integral Human Development and established principles for ethical AI governance that prioritize human dignity over technological advancement. What you should know: The Pontifical Academy of Social Sciences, the Vatican's research body for social issues, organized the "Digital Rerum Novarum" conference on October 16-17, combining academic research with practical AI applications. Participants included leading experts from MIT, Microsoft, Columbia University, the UN, and major European institutions. The conference...